187973-60-0Relevant articles and documents
Macrocyclic glutaminase GLS1 inhibitor or pharmaceutically acceptable salt thereof and preparation method and application thereof
-
Paragraph 0113; 0115; 0118-0119, (2020/08/02)
The invention relates to the field of biological medicine, in particular to a series of macrocyclic glutaminase inhibitors, a synthesis method and medical application thereof, and particularly relatesto prevention or treatment of glutaminase related diseases. Meanwhile, the inventor performs a series of in-vitro anti-tumor activity evaluation on the synthesized compounds, and particularly, most of the compounds have good inhibitory activity on cancer cells.
PYRROLIDINO HETEROCYCLES
-
Paragraph 0407-0409, (2015/03/31)
The invention relates to compounds of formula I wherein A1, A2, A3, B, R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as medicaments.
IMIDAZOLE DERIVATIVES
-
Page/Page column 60, (2015/06/11)
The present invention relates to compounds of formula (I), wherein A, B, R1 and R2 are as defined herein before.